An2 Therapeutics logo

An2 Therapeutics Share Price Today

(NASDAQ: ANTX)

An2 Therapeutics share price is $1.25 & ₹108.71 as on 6 Mar 2025, 2.30 'hrs' IST

$1.25

0.1

(8.7%)

Market is closed - opens 8 PM, 06 Mar 2025

View live An2 Therapeutics share price in Dollar and Rupees. Guide to invest in An2 Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in An2 Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

An2 Therapeutics share price movements

  • Today's Low: $1.14
    Today's High: $1.26

    Day's Volatility :9.52%

  • 52 Weeks Low: $0.87
    52 Weeks High: $3.88

    52 Weeks Volatility :77.58%

An2 Therapeutics (ANTX) Returns

PeriodAn2 Therapeutics, Inc.Index (Russel 2000)
3 Months
-20.69%
0.0%
6 Months
11.65%
0.0%
1 Year
-59.93%
0.0%
3 Years
-92.53%
-11.6%

An2 Therapeutics (ANTX) Key Statistics

in dollars & INR

Previous Close
$1.15
Open
$1.14
Today's High
$1.26
Today's Low
$1.14
Market Capitalization
$34.4M
Today's Volume
$133.8K
52 Week High
$3.88
52 Week Low
$0.87
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-53.56%

How to invest in An2 Therapeutics Stock (ANTX) from India?

It is very easy for Indian residents to invest directly in An2 Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the An2 Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for An2 Therapeutics or ANTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of An2 Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of An2 Therapeutics shares which would translate to 0.696 fractional shares of An2 Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like An2 Therapeutics, in just a few clicks!

Returns in An2 Therapeutics (ANTX) for Indian investors in Rupees

The An2 Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

An2 Therapeutics investment value today

Current value as on today

₹48,517

Returns

₹51,483

(-51.48%)

Returns from An2 Therapeutics Stock

₹56,446 (-56.45%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards An2 Therapeutics (ANTX)

-30%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for An2 Therapeutics Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in An2 Therapeutics

  • BML Capital Management LLC

    19.24%

  • Almitas Capital LLC

    4.39%

  • Vanguard Group Inc

    3.47%

  • Renaissance Technologies Corp

    1.94%

  • Peapod Lane Capital LLC

    1.94%

  • Two Sigma Advisers, LLC

    1.77%

Analyst Recommendation on An2 Therapeutics

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for An2 Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
10
Hold
3
4
1
Sell
0
0
0

Analyst Forecast on An2 Therapeutics Stock (ANTX)

What analysts predicted

Upside of 113.34%

Target:

$2.67

Current:

$1.25

Insights on An2 Therapeutics Stock (Ticker Symbol: ANTX)

  • Price Movement

    In the last 7 days, ANTX stock has moved up by 1.8%
  • ANTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 121.5%

An2 Therapeutics Technicals Summary

Sell

Neutral

Buy

An2 Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

An2 Therapeutics (ANTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
An2 Therapeutics, Inc. logo
3.6%
11.65%
-59.93%
-92.53%
-92.53%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
An2 Therapeutics, Inc. logo
NA
NA
NA
-1.64
-0.54
-0.32
NA
2.94
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
An2 Therapeutics, Inc. logo
Buy
$34.4M
-92.53%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About An2 Therapeutics

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, which is in a pivotal Phase 2/3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease. The company also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize, or otherwise exploit certain compounds and products, including epetraborole, for the treatment, diagnosis, or prevention of all human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize certain compounds and products, including epetraborole, in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Organization
An2 Therapeutics
Employees
41
CEO
Mr. Eric E. Easom
Industry
Services

Management People of An2 Therapeutics

NameTitle
Mr. Eric E. Easom
Co-Founder, CEO, President & Chairman of the Board
Mr. Joseph S. Zakrzewski
Co-Founder & Chairman of the Board
Ms. Lucy O. Day CPA
CFO, Principal Financial Officer & Principal Accounting Officer
Dr. George Harrison Talbot FACP, M.D.
Co-Founder & Senior Clinical Advisor
Dr. Michael R. K. Alley Ph.D.
Co-Founder, Senior VP of Research Fellow & Head of Biology
Mr. Joshua Eizen J.D.
Chief Legal Officer & COO
Dr. Sanjay Chanda Ph.D.
Chief Development Officer
Dr. Stephen David Prior Ph.D.
Chief Strategy Officer
Mr. Vince Hernandez
Senior VP of Research & Head of Chemistry

Important FAQs about investing in ANTX Stock from India :

What is An2 Therapeutics share price today?

An2 Therapeutics share price today stands at $1.25, Open: $1.14 ; Previous Close: $1.15 ; High: $1.26 ; Low: $1.14 ; 52 Week High: $3.88 ; 52 Week Low: $0.87.

The stock opens at $1.14, after a previous close of $1.15. The stock reached a daily high of $1.26 and a low of $1.14, with a 52-week high of $3.88 and a 52-week low of $0.87.

Can Indians buy An2 Therapeutics shares?

Yes, Indians can invest in the An2 Therapeutics (ANTX) from India.

With INDmoney, you can buy An2 Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy An2 Therapeutics at zero transaction cost.

How can I buy An2 Therapeutics shares from India?

It is very easy to buy An2 Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of An2 Therapeutics (ANTX) be purchased?

Yes, you can buy fractional shares of An2 Therapeutics with INDmoney app.

What are the documents required to start investing in An2 Therapeutics stocks?

To start investing in An2 Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of An2 Therapeutics Stock (ANTX)?

Today’s highest price of An2 Therapeutics (ANTX) is $1.26.

Today’s lowest price of An2 Therapeutics (ANTX) is $1.14.

What is today's market capitalisation of An2 Therapeutics?

Today's market capitalisation of An2 Therapeutics ANTX is 34.4M

What is the 52 Week High and Low Range of An2 Therapeutics Stock (ANTX)?

  • 52 Week High

    $3.88

  • 52 Week Low

    $0.87

What are the historical returns of An2 Therapeutics (ANTX)?

  • 1 Month Returns

    3.6%

  • 3 Months Returns

    11.65%

  • 1 Year Returns

    -59.93%

  • 5 Years Returns

    -92.53%

Who is the Chief Executive Officer (CEO) of An2 Therapeutics ?

Mr. Eric E. Easom is the current Chief Executive Officer (CEO) of An2 Therapeutics.